Bristol-Myers Squibb Company
NYSE: BMY
$57.25
+$0.45 (+0.8%)
Real Time Data Delayed 15 Min.
BMY Articles
Reuters: GM (GM) will file for Chapter 11 today. Reuters: Geithner told China its dollar assets are safe. Reuters: A judge approved the sale of most of Chrysler’s assets to a group led...
Published:
Last Updated:
We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend. This is broken down...
Published:
These are the top pre-market analyst downgrades and negative research calls we have seen from Wall Street early this Friday morning: Akamai Tech (AKAM) Cut to Hold at Citigroup. Bristol-Myers Squibb...
Published:
It has been no secret that the market for initial public offerings has been one of the biggest ghost towns in the financial markets. The secondary markets and the bond markets are opening up...
Published:
Last Updated:
If you can believe it, there is an initial public offering on deck this week. Bristol-Myers Squibb Co. (NYSE: BMY) is set to partially spin off Mead Johnson Nutrition (NYSE: MJN). It looks like it is...
Published:
Last Updated:
We haven’t been covering Jim Cramer as much for many different reasons, but we still pay attention when he comes out with stock picks because it can still affect at least the short term trading in...
Published:
Last Updated:
There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions. The FT reported that the world’s largest pharmaceutical company is willing to...
Published:
Last Updated:
People who get to the end of 2008 and are still at work can be thankful. The unemployment rate will probably be over 7%. That does not count the people no longer looking for work. Add them in and the...
Published:
Last Updated:
According to Reuters, the Fed may need to use a trillion dollars to halt the economy from moving into a period of deflation. Reuters reports that OPEC will make the largest production cut in its...
Published:
Last Updated:
There are few positive calls this morning from Wall Street analysts, but these are the ones we have caught this morning: Alcatel-Lucent (ALU) Raised to Sector Perform at RBC. ASUR (ASR) Raised to Buy...
Published:
These are some of the top analyst upgrades we have seen this Friday morning: Abercrombie & Fitch (ANF) Raised to Hold at Jefferies. Bristol-Myers Squibb (BMY) Started as Buy at Goldman Sachs....
Published:
Last Updated:
Analysts assume third quarter earnings for the companies in the S&P 500 will be bad. But, looking at the number which is the average of all firms in the index is misleading. The market will be...
Published:
Last Updated:
Carl Icahn appears to have won a blue ribbon for ImClone Systems (NASDAQ: IMCL) shareholders. The biotech stock is trading up on a very weak trading day after what many had deemed as a fishy merger...
Published:
Last Updated:
ImClone Systems Inc. (NASDAQ: IMCL) is among the biotech bonanza merger candidates with one deal on the table and perhaps an unofficial deal waiting in the wings. Bristol-Myers Squibb Co. (NYSE:...
Published:
Last Updated:
According to Reuters, Wilbur Ross say the bailout package does not address the core of problem which is mortgage payments. Reuters writes that the National Retail Federation says that this will be...
Published:
Last Updated: